A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors

Annals of Nuclear Medicine

Volumn 18, Issue 3, 2004, Pages 235-241

  Nishiyama, Yoshihiro ^a   Yamamoto, Yuka ^a   Yokoe, Koiku ^a   Kawaguchi, Yoji ^b   Toyama, Yoshihiro ^a   Satoh, Katashi ^a   Ohkawa, Motoomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

201Tl; Bone and soft tissue tumor; Recurrence; Scintigraphy

Indexed keywords

THALLIUM 201; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M HYDROXYMETHYLENE DIPHOSPHONATE; THALLIUM; THALLIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOWMETRY; BONE SCINTISCANNING; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SCHOOL CHILD; SCINTISCANNING; SOFT TISSUE TUMOR; THREE PHASE BONE SCINTIGRAPHY; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M MEDRONATE; THALLIUM; TREATMENT OUTCOME;

EID: 3142583357     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985005     Document Type: Article

References (21)

1. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990; 19: 85-90.
2. Davies AM, Vanel D. Follow-up of musculoskeletal tumors. Eur Radiol 1998; 8: 791-799.
3. Kunisada T, Ozaki T, Kawai A, Sugihara S, Taguchi K, Inoue H. Imaging assessment of the response of osteosarcoma patients to preoperative chemotherapy: Angiography compared with thallium-201 scintigraphy. Cancer 1999; 86: 949-956.
4. Salvatore M, Carrati L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: Preliminary experiments. Radiology 1976; 167: 487-488.
5. Goto Y, Ihara K, Kawauchi S, Ohi R, Sasaki K, Kawai S. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 2002; 7: 304-312.
6. Lin J, Leung WT, Ho SK, Ho KC, Kumta SM, Metreweli C, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995; 22: 553-555.
7. Sumiya H, Taki J, Tsuchiya H, Nonomura A, Miyauchi T, Tonami N. Midcourse thallium scintigraphy to predict tumor response in bone and soft-tissue tumors. J Nucl Med 1998; 39: 1600-1604.
8. Ohtomo K, Terui S, Yokoyama R, Abe H, Terauchi T, Maeda G, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996; 37: 1444-1448.
9. Kostakoglu L, Panicek DM, Divgi CR, Botet J, Healey J, Larson SM, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 1995; 22: 1232-1237.
10. Caluser C, Macapinlac HA, Healey JH, Ghavimi F, Meyers P, Wollner N, et al. The relationship between thallium uptake, blood flow and blood pool radioactivity in bone and soft tissue tumors. Clin Nucl Med 1992; 17: 565-572.
11. Caluser C, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med 1994; 21: 1198-1205.
12. Abdel-Dayem HM. The role of nuclear medicine in primary bone and soft tissue tumors. Semin Nucl Med 1997; 27: 355-363.
13. Kirchner PT, Simon MA. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities. J Bone Joint Surg Am 1984; 66: 319-327.
14. m-MDP three-phase dynamic bone scintigraphy. Nucl Med Commun 1999; 20: 41-48.
15. Nishiyama Y, Yamamoto Y, Toyama Y, Satoh K, Ohkawa M, Tanabe M. Diagnostic value of Tl-201 and three-phase bone scintigraphy for bone and soft-tissue tumors. Clin Nucl Med 2000; 25: 200-205.
16. Lindner NJ, Ramm O, Hillmann A, Roedl R, Gosheger G, Brinkschmidt C, et al. Limb salvage and outcome of osteosarcoma: the University of Muenster experience. Clin Orthop 1999; 358: 83-89.
17. Weis LD. The success of limb-salvage surgery in the adolescent patient with osteogenic sarcoma. Adolesc Med 1999; 10: 451-458.
18. Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H. Value of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 1998; 3: 297-303.
19. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997; 27: 334-345.
20. 67Ga single photon emission tomography in the diagnosis of head and neck cancer recurrence. Nucl Med Commun 2002; 23: 187-191.
21. Bredella MA, Caputo GR, Steinbach LS. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. AJR 2002; 179: 1145-1159.